Open access · CC-BY
via OpenAlex
Nicotinamide riboside and caffeine partially restore diminished NAD availability but not altered energy metabolism in Alzheimer's disease
Woo‐In Ryu, Minqi Shen, Yoon Lee, Ryan A. Healy, Mariana K. Bormann, Bruce M. Cohen, Kai‐Christian Sonntag
Aging Cell · 2022 · ▲ 18 citations
Abstract
The redox co-factor nicotinamide adenine dinucleotide (NAD) declines with age, and NAD deficits are specifically associated with dysfunctional energy metabolism in late-onset Alzheimer's disease (LOAD). Nicotinamide riboside (NR), a dietary NAD precursor, has been suggested to ameliorate the aging process or neurodegeneration. We assessed whether NR with or without caffeine, which increases nicotinamide mononucleotide transferase subtype 2 (NMNAT2), an essential enzyme in NAD production, modulates bioenergetic functions in LOAD. In LOAD patients-and young or old control individuals-derived dermal fibroblasts as well as in induced pluripotent stem cell-differentiated neural progenitors and astrocytes, NR and caffeine cell type-specifically increased the NAD pool, transiently enhanced mitochondrial respiration or glycolysis and altered the expression of genes in the NAD synthesis or consumption pathways. However, continued treatment led to reversed bioenergetic effects. Importantly, NR and caffeine did not alter the characteristics of a previously documented inherent LOAD-associated bioenergetic phenotype. Thus, although NR and caffeine can partially restore diminished NAD availability, increasing NAD alone may not be sufficient to boost or restore energy metabolism in brain aging or alter aberrant energy management in LOAD. Nicotinamide riboside might still be of value in combination with other agents in preventive or therapeutic intervention strategies to address the aging process or age-associated dementia.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/acel.13658
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Ryu, W., Shen, M., Lee, Y., Healy, R.A., Bormann, M.K., Cohen, B.M., & Sonntag, K. (2022). Nicotinamide riboside and caffeine partially restore diminished NAD availability but not altered energy metabolism in Alzheimer's disease. <em>Aging Cell</em>. https://doi.org/10.1111/acel.13658
Vancouver
Ryu W, Shen M, Lee Y, Healy RA, Bormann MK, Cohen BM, et al. Nicotinamide riboside and caffeine partially restore diminished NAD availability but not altered energy metabolism in Alzheimer's disease. Aging Cell. 2022. doi:10.1111/acel.13658.
BibTeX
@article{wooin2022Nicoti,
title = {Nicotinamide riboside and caffeine partially restore diminished NAD availability but not altered energy metabolism in Alzheimer's disease},
author = {Woo‐In Ryu and Minqi Shen and Yoon Lee and Ryan A. Healy and Mariana K. Bormann and Bruce M. Cohen and Kai‐Christian Sonntag},
journal = {Aging Cell},
year = {2022},
doi = {10.1111/acel.13658},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
npj Aging and Mechanisms of Disease 2021
Open access · CC-BY
A decrease in NAD+ contributes to the loss of osteoprogenitors and bone mass with aging
Advanced Functional Materials 2025
Open access · OA
Nanopore Identification of Nicotinamide Adenine Nucleotide and Its Derivatives
British Journal Of Nutrition 2014
Open access · OA
Methionine deficiency does not increase polyamine turnover through depletion of hepatic S-adenosylmethionine in juvenile Atlantic salmon
International Journal of Biological Sciences 2019
Open access · CC-BY
Nicotinamide Riboside Enhances Mitochondrial Proteostasis and Adult Neurogenesis through Activation of Mitochondrial Unfolded Protein Response Signaling in the Brain of ALS SOD1G93A Mice
International Journal of Molecular Sciences 2025
Open access · CC-BY
Preventive and Protective Effects of Nicotinamide Adenine Dinucleotide Boosters in Aging and Retinal Diseases
Toxins 2021
Open access · CC-BY